Pays
Auteurs
Exploration
Accueil
Racine
Exploration
Accueil
Racine

La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Canada7508
A Jon Stoessl49
Canada Sauf A Jon Stoessl" 7463
A Jon Stoessl Sauf Canada" 4
Canada Et A Jon Stoessl 45
Canada Ou A Jon Stoessl 7512
Corpus8669
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 45.
Ident.Authors (with country if any)Title
000029 Daryl J. Wile [Canada] ; Pankaj A. Agarwal [Inde] ; Michael Schulzer [Canada] ; Edwin Mak [Canada] ; Katherine Dinelle [Canada] ; Elham Shahinfard [Canada] ; Nasim Vafai [Canada] ; Kazuko Hasegawa [Japon] ; Jing Zhang [États-Unis] ; Jessamyn Mckenzie [Canada] ; Nicole Neilson [Canada] ; Audrey Strongosky [États-Unis] ; Ryan J. Uitti [États-Unis] ; Mark Guttman [Canada] ; Cyrus P. Zabetian [États-Unis] ; Yu-Shin Ding [États-Unis] ; Mike Adam [Canada] ; Jan Aasly [Norvège] ; Zbigniew K. Wszolek [États-Unis] ; Matthew Farrer [Canada] ; Vesna Sossi [Canada] ; A Jon Stoessl [Canada]Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.
000034 Jeffrey H. Kordower [États-Unis] ; Christopher G. Goetz [États-Unis] ; Yaping Chu [États-Unis] ; Glenda M. Halliday [Australie] ; Daniel A. Nicholson [États-Unis] ; Timothy F. Musial [États-Unis] ; David J. Marmion [États-Unis] ; A Jon Stoessl [Canada] ; Vesna Sossi [Canada] ; Thomas B. Freeman [États-Unis] ; C Warren Olanow [États-Unis]Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a Parkinson disease patient.
000082 Andrew J. Perrin [Canada] ; Ekaterina Nosova [Canada] ; Kim Co [Canada] ; Adam Book [Canada] ; Oscar Iu [Canada] ; Vanessa Silva [Canada] ; Christina Thompson [Canada] ; Martin J. Mckeown [Canada] ; A Jon Stoessl [Canada] ; Matthew J. Farrer [Canada] ; Silke Appel-Cresswell [Canada]Gender differences in Parkinson's disease depression.
000163 Musleh A. Algarni [Canada] ; A Jon Stoessl [Canada]The role of biomarkers and imaging in Parkinson's disease.
000262 Julieta E. Arena [Canada] ; A Jon Stoessl [Canada]Optimizing diagnosis in Parkinson's disease: Radionuclide imaging.
000278 A Jon Stoessl [Canada] ; Martin J. Mckeown [Canada]Movement disorders.
000308 Zuzanna Kurowska [États-Unis] ; Jeffrey H. Kordower [États-Unis] ; A Jon Stoessl [Canada] ; Robert E. Burke [États-Unis] ; Patrik Brundin [États-Unis] ; Zhenyu Yue [États-Unis] ; Scott T. Brady [États-Unis] ; Jeffrey Milbrandt [États-Unis] ; Bruce D. Trapp [États-Unis] ; Todd B. Sherer [États-Unis] ; Satish Medicetty [États-Unis]Is Axonal Degeneration a Key Early Event in Parkinson's Disease?
000407 A Jon Stoessl [Canada]Comment: Increased D3 binding-A substrate for levodopa-induced dyskinesias?
000691 A Jon Stoessl [Canada]Imaging in Parkinson's disease: time to look below the neck.
000804 Grace Lee [Canada] ; Adrian C. Byram [Canada] ; Adrian M. Owen [Canada] ; Urs Ribary [Canada] ; A Jon Stoessl [Canada] ; Andrea Townson [Canada] ; Christine Stables [Canada] ; Judy Illes [Canada]Canadian perspectives on the clinical actionability of neuroimaging in disorders of consciousness.
000903 Danielle K. Murray [Canada] ; Matthew A. Sacheli [Canada] ; Janice J. Eng [Canada] ; A Jon Stoessl [Canada]The effects of exercise on cognition in Parkinson’s disease: a systematic review
000A60 A Jon Stoessl [Canada]Gene therapy for Parkinson's disease: a step closer?
000B01 A Jon Stoessl [Canada]Developments in neuroimaging: positron emission tomography.
000B11 A Jon Stoessl [Canada] ; Glenda M. HallidayDAT-SPECT diagnoses dopamine depletion, but not PD.
000B26 Silke Appel-Cresswell [Canada] ; Ali H. Rajput ; Vesna Sossi ; Christina Thompson ; Vanessa Silva ; Jessamyn Mckenzie ; Katherine Dinelle ; Siobhan E. Mccormick ; Carles Vilari O-Güell ; A Jon Stoessl ; Dennis W. Dickson ; Chris A. Robinson ; Matthew J. Farrer ; Alex RajputClinical, positron emission tomography, and pathological studies of DNAJC13 p.N855S Parkinsonism.
000B35 Matthew D. Walker [Canada] ; Mattia Volta [Canada] ; Stefano Cataldi [Canada] ; Katherine Dinelle [Canada] ; Dayne Beccano-Kelly [Canada] ; Lise Munsie [Canada] ; Rick Kornelsen [Canada] ; Chenoa Mah [Canada] ; Patrick Chou [Canada] ; Kimberley Co [Canada] ; Jaskaran Khinda [Canada] ; Marta Mroczek [Canada] ; Sabrina Bergeron [Canada] ; Katrina Yu [Canada] ; Li Ping Cao [Canada] ; Natalja Funk [Allemagne] ; Thomas Ott [Allemagne] ; Dagmar Galter [Suède] ; Olaf Riess [Allemagne] ; Saskia Biskup [Allemagne] ; Austen J. Milnerwood [Canada] ; A Jon Stoessl [Canada] ; Matthew J. Farrer [Canada] ; Vesna Sossi [Canada]Behavioral deficits and striatal DA signaling in LRRK2 p.G2019S transgenic rats: a multimodal investigation including PET neuroimaging.
000B64 Shinsuke Fujioka [États-Unis] ; Bradley F. Boeve [États-Unis] ; Joseph E. Parisi [États-Unis] ; Pawel Tacik [États-Unis] ; Naoya Aoki [États-Unis] ; Audrey J. Strongosky [États-Unis] ; Matt Baker [États-Unis] ; Monica Sanchez-Contreras [États-Unis] ; Owen A. Ross [États-Unis] ; Rosa Rademakers [États-Unis] ; Vesna Sossi [Canada] ; Dennis W. Dickson [États-Unis] ; A Jon Stoessl [Canada] ; Zbigniew K. Wszolek [États-Unis]A familial form of parkinsonism, dementia, and motor neuron disease: a longitudinal study.
000D16 Marjorie E. Gonzalez [Canada] ; Katherine Dinelle ; Nasim Vafai ; Nicole Heffernan ; Jess Mckenzie ; Silke Appel-Cresswell ; Martin J. Mckeown ; A Jon Stoessl ; Vesna SossiNovel spatial analysis method for PET images using 3D moment invariants: applications to Parkinson's disease.
000D37 Danielle Murray [Canada] ; A Jon StoesslMechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions.
000E13 Madeleine E. Sharp [Canada] ; Jayalakshmi Viswanathan ; Martin J. Mckeown ; Silke Appel-Cresswell ; A Jon Stoessl ; Jason J S. BartonDecisions under risk in Parkinson's disease: preserved evaluation of probability and magnitude.
001171 A Jon Stoessl [Canada]Neuroimaging in the early diagnosis of neurodegenerative disease
001172 A Jon Stoessl [Canada]Neuroimaging in Parkinson's disease: from pathology to diagnosis.
001216 Oury Monchi [Canada] ; A Jon StoesslImaging neural correlates of mild cognitive impairment in Parkinson's disease.
001631 A Jon Stoessl [Canada]Movement disorders: new insights into Parkinson's disease.
001641 Ramachandiran Nandhagopal [Canada] ; Lisa Kuramoto ; Michael Schulzer ; Edwin Mak ; Jacqueline Cragg ; Jess Mckenzie ; Siobhan Mccormick ; Thomas J. Ruth ; Vesna Sossi ; Raul De La Fuente-Fernandez ; A Jon StoesslLongitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease.
001728 A Jon Stoessl [Canada] ; Wr Wayne Martin ; Martin J. Mckeown ; Vesna SossiAdvances in imaging in Parkinson's disease.
001A33 Renju Kuriakose [Canada] ; A Jon StoesslImaging the nigrostriatal system to monitor disease progression and treatment-induced complications.
001A52 Sarah C. Lidstone [Canada] ; Michael Schulzer ; Katherine Dinelle ; Edwin Mak ; Vesna Sossi ; Thomas J. Ruth ; Raul De La Fuente-Fernández ; Anthony G. Phillips ; A Jon StoesslEffects of expectation on placebo-induced dopamine release in Parkinson disease.
001D51 Raúl De La Fuente-Fernández [Canada] ; Vesna Sossi ; Siobhan Mccormick ; Michael Schulzer ; Thomas J. Ruth ; A Jon StoesslVisualizing vesicular dopamine dynamics in Parkinson's disease.
001D81 A Jon Stoessl [Canada]Radionuclide scanning to diagnose Parkinson disease: is it cost-effective?
001E46 A Jon Stoessl [Canada]Functional imaging studies of non-motoric manifestations of Parkinson's Disease.
001E55 Vesna Sossi [Canada] ; Katherine Dinelle ; Geoffrey J. Topping ; James E. Holden ; Doris Doudet ; Michael Schulzer ; Thomas J. Ruth ; A Jon Stoessl ; Raul De La Fuente-FernandezDopamine transporter relation to levodopa-derived synaptic dopamine in a rat model of Parkinson's: an in vivo imaging study.
002192 R. Nandhagopal [Canada] ; Martin J. Mckeown ; A Jon StoesslFunctional imaging in Parkinson disease.
002446 A Jon Stoessl [Canada]Positron emission tomography in premotor Parkinson's disease.
002471 A Jon Stoessl [Canada]Gene therapy for Parkinson's disease: early data.
002950 Donald Calne [Canada] ; Michael Schulzer ; Edwin Mak ; A Jon StoesslTreatment for the progression of Parkinson's disease.
002968 Wing Lok Au [Canada] ; John R. Adams ; André R. Troiano ; A Jon StoesslParkinson's disease: in vivo assessment of disease progression using positron emission tomography.
002D82 Zhigao Huang [Canada] ; Raúl De La Fuente-Fernández ; A Jon StoesslEtiology of Parkinson's disease.
002D86 A Jon Stoessl [Canada] ; Raúl De La Fuente-FernándezDopamine receptors in Parkinson's disease: imaging studies.
002D98 A Jon Stoessl [Canada]Agonizing over dopaminergic replacement therapy--lessons from animal models of Parkinson's disease.
002F58 Raúl De La Fuente-Fernández [Canada] ; A Jon StoesslThe placebo effect in Parkinson's disease.
002F66 Raúl De La Fuente-Fernández [Canada] ; A Jon StoesslParkinson's disease: imaging update.
003B03 Yue Wang [Canada] ; Ian Turnbull [Canada] ; Susan Calne [Canada] ; A Jon Stoessl [Canada] ; Donald B. Calne [Canada]Pallidotomy for tardive dyskinesia
005580 A Jon Stoessl [Canada] ; Raúl De La Fuente-FernándezWilling oneself better on placebo--effective in its own right.
005583 Sarah C Christine Lidstone [Canada] ; A Jon StoesslUnderstanding the placebo effect: contributions from neuroimaging.
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022